ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
84 hedge funds and large institutions have $243M invested in Adamas Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 14 closing their positions.
Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
2.24%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
14
Increased
30
Reduced
23
Closed
14
Calls
–
Puts
$332K
Net Calls
-$332K
Net Calls Change
-$369K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$8.43M |
| 2 |
BS
2
Bow Street
New York
|
$7.37M |
| 3 |
BWCA
3
Brenner West Capital Advisors
New York
|
$15.4M |
| 4 |
BOS
4
Bingham Osborn & Scarborough
San Francisco,
California
|
$3.56M |
| 5 |
JGC
5
J. Goldman & Co
New York
|
$2.56M |
